Clinical Trial Update: A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating subcutaneous adalimumab (Humira) in adults with moderate to severe Crohn's disease, focusing on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Status: COMPLETED